About the Company
ExpreS2ion Biotechnologies is a world leading CRO biotech company
within protein production in Drosophila Schneider-2 (S2)
cells. Our company has a proprietary and complete S2
recombinant protein technology base. We have in-depth
practical experience with the Drosophila S2 expression
technology for the production of recombinant proteins for
preclinical development and for use in clinical trials.
ExpreS2ion Biotechnologies offers services related to vector development,
cell line development, cloning, upstream development
and optimization, and production of GLP material. ExpreS2ion Biotechnologies can facilitate GMP production scale-up in collaboration
with our own preferred CMO partners or with the customer
or their preferred CMO.
Products
Fast Custom Protein Production for your research needs.
Highly effective Transfection Reagents for multiple cell types.
News
May 2012
ExpreS2ion Biotechnologies will be in Cambridge, UK to participate in the Life Sciences Leadership series organized by OneNucleus: "Infectious diseases and Vaccines", 17 May 2012.
May 2012
ExpreS2ion Biotechnologies is participating in the "B4B Connection Oncologie", Paris, France, 23-24 May
May 2012
ExpreS2ion Biotechnologies will be attending the 2nd annual Non-Antibody Protein Production Conference, Prague, Czech Republic, 24-25 May